Correlation Between Newron Pharmaceuticals and Emmi AG
Can any of the company-specific risk be diversified away by investing in both Newron Pharmaceuticals and Emmi AG at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Newron Pharmaceuticals and Emmi AG into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Newron Pharmaceuticals SpA and Emmi AG, you can compare the effects of market volatilities on Newron Pharmaceuticals and Emmi AG and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Newron Pharmaceuticals with a short position of Emmi AG. Check out your portfolio center. Please also check ongoing floating volatility patterns of Newron Pharmaceuticals and Emmi AG.
Diversification Opportunities for Newron Pharmaceuticals and Emmi AG
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Newron and Emmi is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Newron Pharmaceuticals SpA and Emmi AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emmi AG and Newron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Newron Pharmaceuticals SpA are associated (or correlated) with Emmi AG. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emmi AG has no effect on the direction of Newron Pharmaceuticals i.e., Newron Pharmaceuticals and Emmi AG go up and down completely randomly.
Pair Corralation between Newron Pharmaceuticals and Emmi AG
Assuming the 90 days trading horizon Newron Pharmaceuticals SpA is expected to generate 4.4 times more return on investment than Emmi AG. However, Newron Pharmaceuticals is 4.4 times more volatile than Emmi AG. It trades about 0.03 of its potential returns per unit of risk. Emmi AG is currently generating about -0.02 per unit of risk. If you would invest 586.00 in Newron Pharmaceuticals SpA on August 24, 2024 and sell it today you would earn a total of 134.00 from holding Newron Pharmaceuticals SpA or generate 22.87% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Newron Pharmaceuticals SpA vs. Emmi AG
Performance |
| Timeline |
| Newron Pharmaceuticals |
| Emmi AG |
Newron Pharmaceuticals and Emmi AG Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Newron Pharmaceuticals and Emmi AG
The main advantage of trading using opposite Newron Pharmaceuticals and Emmi AG positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Newron Pharmaceuticals position performs unexpectedly, Emmi AG can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emmi AG will offset losses from the drop in Emmi AG's long position.| Newron Pharmaceuticals vs. Santhera Pharmaceuticals Holding | Newron Pharmaceuticals vs. Basilea Pharmaceutica AG | Newron Pharmaceuticals vs. Addex Therapeutics | Newron Pharmaceuticals vs. Evolva Holding SA |
| Emmi AG vs. Santhera Pharmaceuticals Holding | Emmi AG vs. Newron Pharmaceuticals SpA | Emmi AG vs. Basilea Pharmaceutica AG | Emmi AG vs. Evolva Holding SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |